Henry Schein (HSIC) Competitors

Henry Schein (NASDAQ:HSIC) and Cardinal Health (NYSE:CAH) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, media sentiment, profitability, valuation, dividends, analyst recommendations, risk and community ranking.

Is HSIC or CAH more profitable?

Henry Schein has a net margin of 2.51% compared to Cardinal Health's net margin of 0.59%. Henry Schein's return on equity of 12.90% beat Cardinal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Henry Schein	2.51%	12.90%	5.21%
Cardinal Health	0.59%	-59.57%	4.17%

Does the media refer more to HSIC or CAH?

In the previous week, Cardinal Health had 31 more articles in the media than Henry Schein. MarketBeat recorded 43 mentions for Cardinal Health and 12 mentions for Henry Schein. Henry Schein's average media sentiment score of 1.28 beat Cardinal Health's score of 1.25 indicating that Henry Schein is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Henry Schein	9 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cardinal Health	33 Very Positive mention(s)	3 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts recommend HSIC or CAH?

Henry Schein presently has a consensus target price of $81.10, indicating a potential upside of 21.79%. Cardinal Health has a consensus target price of $140.14, indicating a potential upside of 2.32%. Given Henry Schein's higher probable upside, research analysts plainly believe Henry Schein is more favorable than Cardinal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Henry Schein	0 Sell rating(s)	5 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.64
Cardinal Health	0 Sell rating(s)	4 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.71

Does the MarketBeat Community prefer HSIC or CAH?

Cardinal Health received 544 more outperform votes than Henry Schein when rated by MarketBeat users. Likewise, 71.44% of users gave Cardinal Health an outperform vote while only 51.63% of users gave Henry Schein an outperform vote.

Company	Underperform	Outperform
Henry Schein	Outperform Votes 379 51.63%	Underperform Votes 355 48.37%
Cardinal Health	Outperform Votes 923 71.44%	Underperform Votes 369 28.56%

Which has more volatility and risk, HSIC or CAH?

Henry Schein has a beta of 0.84, indicating that its stock price is 16% less volatile than the S&P 500. Comparatively, Cardinal Health has a beta of 0.66, indicating that its stock price is 34% less volatile than the S&P 500.

Do insiders and institutionals have more ownership in HSIC or CAH?

96.6% of Henry Schein shares are owned by institutional investors. Comparatively, 87.2% of Cardinal Health shares are owned by institutional investors. 1.1% of Henry Schein shares are owned by company insiders. Comparatively, 0.1% of Cardinal Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Which has higher valuation and earnings, HSIC or CAH?

Cardinal Health has higher revenue and earnings than Henry Schein. Henry Schein is trading at a lower price-to-earnings ratio than Cardinal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Henry Schein	$12.67B	0.65	$416M	$3.04	21.90
Cardinal Health	$222.28B	0.15	$852M	$5.36	25.55

Summary

Henry Schein beats Cardinal Health on 11 of the 19 factors compared between the two stocks.